Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

650 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy.
Rizzo A, Pozza G, Salari F, Giacomelli A, Mileto D, Cossu MV, Mancon A, Gagliardi G, Micol B, Micheli V, Capetti A, Antinori S, Gismondo MR, Olivieri P, Lombardi A. Rizzo A, et al. Among authors: gagliardi g. J Med Virol. 2023 Jan;95(1):e28328. doi: 10.1002/jmv.28328. Epub 2022 Nov 28. J Med Virol. 2023. PMID: 36415133
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus.
Mancon A, Raccagni AR, Gagliardi G, Moschese D, Rizzo A, Giacomelli A, Cutrera M, Salari F, Bracchitta F, Antinori S, Gori A, Rizzardini G, Castagna A, Gismondo MR, Nozza S, Mileto D. Mancon A, et al. Among authors: gagliardi g. Emerg Microbes Infect. 2024 Dec;13(1):2337666. doi: 10.1080/22221751.2024.2337666. Epub 2024 Apr 14. Emerg Microbes Infect. 2024. PMID: 38572513 Free PMC article.
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.
Candela C, Raccagni AR, Bruzzesi E, Bertoni C, Rizzo A, Gagliardi G, Canetti D, Gianotti N, Mileto D, Gismondo MR, Castagna A, Nozza S; Centro San Luigi (CSL) Working Group. Candela C, et al. Among authors: gagliardi g. Viruses. 2023 Mar 2;15(3):667. doi: 10.3390/v15030667. Viruses. 2023. PMID: 36992376 Free PMC article.
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
Pezzati L, Giacomelli A, Mileto D, Conti F, Gagliardi G, Rizzo A, Milazzo L, Schiuma M, Covizzi A, Siano M, Bassoli C, Passerini M, Piscaglia M, Torre A, Oreni L, Rizzardini G, Galli M, Ridolfo AL, Antinori S. Pezzati L, et al. Among authors: gagliardi g. J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.029. Epub 2021 May 29. J Infect. 2021. PMID: 34062183 Free PMC article. No abstract available.
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.
Mileto D, Fenizia C, Cutrera M, Gagliardi G, Gigantiello A, De Silvestri A, Rizzo A, Mancon A, Bianchi M, De Poli F, Cuomo M, Burgo I, Longo M, Rimoldi SG, Pagani C, Grosso S, Micheli V, Rizzardini G, Grande R, Biasin M, Gismondo MR, Lombardi A. Mileto D, et al. Among authors: gagliardi g. Emerg Microbes Infect. 2021 Dec;10(1):2235-2243. doi: 10.1080/22221751.2021.2004866. Emerg Microbes Infect. 2021. PMID: 34749573 Free PMC article.
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees' sera: a preliminary evaluation.
Mileto D, Micheli V, Fenizia C, Cutrera M, Gagliardi G, Mancon A, Bracchitta F, De Silvestri A, Rizzardini G, Lombardi A, Biasin M, Gismondo MR. Mileto D, et al. Among authors: gagliardi g. Emerg Microbes Infect. 2022 Dec;11(1):790-792. doi: 10.1080/22221751.2022.2045878. Emerg Microbes Infect. 2022. PMID: 35196967 Free PMC article. No abstract available.
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, Dedivitiis G, Meraviglia P, Pellicciotta M, Armiento L, Cossu MV, Rizzardini G. Capetti AF, et al. Among authors: gagliardi g. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.023. Epub 2021 May 27. J Infect. 2021. PMID: 34052240 Free PMC article.
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects.
Borgonovo F, Stangalini CA, Tinelli C, Mariani C, Mileto D, Cossu MV, Abbati L, Bilardo L, Gagliardi G, Cutrera M, Pellicciotta M, Armiento L, Dedivitiis G, Capetti AF, Rizzardini G. Borgonovo F, et al. Among authors: gagliardi g. Hum Vaccin Immunother. 2022 Nov 30;18(5):2060018. doi: 10.1080/21645515.2022.2060018. Epub 2022 May 5. Hum Vaccin Immunother. 2022. PMID: 35511791 Free PMC article.
650 results